Guided Therapeutics, Inc.
corporate_fare Company Profile
Guided Therapeutics, Inc. (OTC:GTHP) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 8 items for GTHP at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-16, rated 8/10. Across its 8 most recent items scored 7 or higher, the top rating is 9/10, with 6 rated 8 or above. Recent SEC coverage for GTHP spans 10-Q, 4, 10-K, 8-K.
Recent high-impact activity:
- Guided Therapeutics Q3: $111K Cash, Going Concern, Material Weaknesses, New $0.20 Tranche
- Guided Therapeutics Q2 2026: Wider Losses, $12K Cash, Going Concern Warning Reiterated
- Guided Therapeutics Posts $0 Revenue, $1.01M Q1 Loss; Advances FDA PMA Filing for Key Device
- GUIDED THERAPEUTICS Reports Widening Q1 Loss, Reiterates Going Concern Warning Amid Heavy Dilution
- Director & 10% Owner Exercises Warrants for $200K, Converts Preferred Stock, Increasing Common Holdings
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 2,817 shares in GTHP as of the October 30, 2026 settlement, a 63.4% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On November 16, 2026, 100.0% of GTHP volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.